2312-3893

2312-3893

S2312-38932024000100016

10.18004/rvspmi/2312-3893/2024.e11122418

Perú

USA

Peru

00 00 2024

00 00 2024

11 1 16

1

2016 151 4 4

395-6

2

2020 12 1 1

3

2015 133 1 1

36-42

4

2022 17 02 02

1-12

5

2018

6

2014 28 1 1

18-22

7

2019

8

2017 11 2 2

151-5

9

2019 14 3 3

103-15

10

2018 25 1 1

35-43

11

2024 22 4 4

277-8

12

2015 372 19 19

1832-43

13

2018 113 7 7

639-46

14

2019

15

2008 39 3 3

571-4

16

2008 48 12 12

2531-9

17

2012 34 5 5

356-60

18

2016 10 2 2

122-6

19

2024 39 5 5

20

2022 44 4 4

512-8

21

2010 13 1 1

5-8

22

2010 8 4 4

278-87

23

2002 42 2 2

216-25

24

2018 13 10 10

25

2004 44 10 10

1417-26

26

2018

27

2008 112 11 11

3449

28

2013 29 1 1

26-30

29

2008 57 8 8

548-50

30

2011

31

2015 92 11 11

1004-11

32

2014 8 7 7

FC01-3

33

2022 106 3 3

288-98

34

Food and Drug Administration, HHS

2015 80 99 99

29841-906

35

Association for the Advancement of Blood & Biotherapies (AABB) 2015

36

2021 69 5 5

962-9